Moreover, NAFLD risk is disproportionately higher among Hispanic youth where elevated ALT levels have been reported in more than 11% of Hispanic adolescents in the US [9], almost 24% of overweight Hispanic youth [10], and as many as 60% of obese Hispanic youth in a clinical sample [11]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.